Both in Pharmaceuticals
Nuvation Bio vs UroGen Pharma
Over the past year NUVB returned +74.5% and URGN returned +111.3%; their daily moves had a correlation of 0.34.
NUVB +74.5% URGN +111.3%Growth of $1, one year, split-adjusted
| Metric | NUVB | URGN |
|---|---|---|
| Price | $5.62 | $40.45 |
| Market cap | $1.97B | $1.98B |
| Today | +0.36% | −1.10% |
| 1 month | −15.6% | −7.3% |
| 6 months | +38.8% | +137.9% |
| Year to date | −37.3% | +72.7% |
| 1 year | +75.6% | +120.6% |
| Revenue growth (YoY) | +555.6% | +199.2% |
| Gross margin | 73.0% | 90.9% |
| Net margin | −198.3% | −19.8% |
| P/E (TTM) | — | — |
| Price / sales | 11.6× | 10.5× |
| Net cash | $399.4M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | 54.8% | 52.3% |
| Short % of float | 22.0% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).